Skip to main content
NCBI home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
editorial
. 2008 Jan 25;9(1):3–4. doi: 10.1007/s10194-008-0010-5

More lessons for the treatment of chronic daily headache

Julio Pascual 1,✉, Purificación Cacabelos 1
PMCID: PMC3476168  PMID: 18219444

Full Text

The Full Text of this article is available as a PDF (129.0 KB).

References

  • 1.Yurekli VA, Akhan G, Kutluhan S, Uzar E, Uzar E, Koyuncuoglu HR, Gultekin F (2008) The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 9. 10.1007/s10194-008-0002-5 [DOI] [PMC free article] [PubMed]
  • 2.Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache. 1991;31:71–74. doi: 10.1111/j.1526-4610.1991.hed3102071.x. [DOI] [PubMed] [Google Scholar]
  • 3.Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache. 2001;41:271–278. doi: 10.1046/j.1526-4610.2001.111006271.x. [DOI] [PubMed] [Google Scholar]
  • 4.Silvestrini M, Bartolini M, Coccia M, Barufaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia. 2003;23:820–824. doi: 10.1046/j.1468-2982.2003.00592.x. [DOI] [PubMed] [Google Scholar]
  • 5.Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007;47:170–180. doi: 10.1111/j.1526-4610.2006.00684.x. [DOI] [PubMed] [Google Scholar]
  • 6.Diener HC, Bussone G, Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TIPMAT-MIG 201 (TOP-CHROME) Study Group Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27:814–823. doi: 10.1111/j.1468-2982.2007.01326.x. [DOI] [PubMed] [Google Scholar]
  • 7.Pascual J, Leira R, Lainez JM. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valpoate in 52 resistant migraine patients. Cephalalgia. 2003;23:961–962. doi: 10.1046/j.1468-2982.2003.00615.x. [DOI] [PubMed] [Google Scholar]
  • 8.Pascual J, Rivas MT, Leira R. Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand. 2007;115:81–83. doi: 10.1111/j.1600-0404.2006.00772.x. [DOI] [PubMed] [Google Scholar]
  • 9.Pascual J, El Berdei Y, Gómez-Sánchez JC. How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate. J Headache Pain. 2007;8:90–93. doi: 10.1007/s10194-007-0351-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dodick D, Mauskop A, Elkind AH, DeGaryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized, double-blind, placebo controlled study. Headache. 2005;45:315–324. doi: 10.1111/j.1526-4610.2005.05068.x. [DOI] [PubMed] [Google Scholar]
  • 11.Ambrosini A. Occipital nerve stimulation for intractable cluster headache. Lancet. 2007;369:1063–1065. doi: 10.1016/S0140-6736(07)60377-8. [DOI] [PubMed] [Google Scholar]
  • 12.Pascual J. Good news for chronic migraine. J Headache Pain. 2006;7:185–187. doi: 10.1007/s10194-006-0311-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES